NIOX Group PLC - Asset Resilience Ratio

Latest as of June 2018: 2.63%

NIOX Group PLC (NIOX) has an Asset Resilience Ratio of 2.63% as of June 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is NIOX Group PLC's working capital to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

GBX10.00 Million
≈ $1.22K USD Cash + Short-term Investments

Total Assets

GBX380.80 Million
≈ $46.33K USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2013–2017)

This chart shows how NIOX Group PLC's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see NIOX asset base.

Liquid Assets Composition Over Time

This chart breaks down NIOX Group PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read NIOX Group PLC (NIOX) total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents GBX0.00 0%
Short-term Investments GBX10.00 Million 2.63%
Total Liquid Assets GBX10.00 Million 2.63%

Asset Resilience Insights

  • Limited Liquidity: NIOX Group PLC maintains only 2.63% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

NIOX Group PLC Industry Peers by Asset Resilience Ratio

Compare NIOX Group PLC's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Eurobio Scientific SA
PA:ALERS
Medical Devices 10.52%
Profound Medical Corp
TO:PRN
Medical Devices 67.66%
EBR Systems Inc
AU:EBR
Medical Devices 54.70%
Epitomee Medical Ltd
TA:EPIT
Medical Devices 0.24%
Cleo Diagnostics Ltd
AU:COV
Medical Devices 94.64%
Aligned Genetics Inc
KQ:238120
Medical Devices 2.22%

Annual Asset Resilience Ratio for NIOX Group PLC (2013–2017)

The table below shows the annual Asset Resilience Ratio data for NIOX Group PLC.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2017-12-31 3.73% GBX15.00 Million
≈ $1.83K
GBX402.40 Million
≈ $48.96K
0.00pp
2017-12-30 3.73% GBX15.00 Million
≈ $1.83K
GBX402.40 Million
≈ $48.96K
-2.26pp
2016-12-31 5.99% GBX20.00 Million
≈ $2.43K
GBX334.10 Million
≈ $40.65K
0.00pp
2016-12-30 5.99% GBX20.00 Million
≈ $2.43K
GBX334.10 Million
≈ $40.65K
-1.74pp
2015-12-31 7.73% GBX37.80 Million
≈ $4.60K
GBX489.20 Million
≈ $59.52K
0.00pp
2015-12-30 7.73% GBX37.80 Million
≈ $4.60K
GBX489.20 Million
≈ $59.52K
-70.53pp
2014-12-31 78.25% GBX156.90 Million
≈ $19.09K
GBX200.50 Million
≈ $24.40K
0.00pp
2014-12-30 78.25% GBX156.90 Million
≈ $19.09K
GBX200.50 Million
≈ $24.40K
+59.73pp
2013-12-31 18.53% GBX7.05 Million
≈ $857.42
GBX38.03 Million
≈ $4.63K
0.00pp
2013-12-30 18.53% GBX7.05 Million
≈ $857.42
GBX38.03 Million
≈ $4.63K
--
pp = percentage points

About NIOX Group PLC

LSE:NIOX UK Medical Devices
Market Cap
$3.43 Million
GBX28.20 Billion GBX
Market Cap Rank
#29344 Global
#563 in UK
Share Price
GBX67.00
Change (1 day)
+0.00%
52-Week Range
GBX54.40 - GBX76.00
All Time High
GBX306.79
About

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide … Read more